Articles by Jim Miller - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jim Miller

Industry Outlook: Down But Not Out

The contract services industry may not be as robust in 2009 as it has been in previous years, but it's not as bad as many people think.
Aug 1, 2009

The contract services industry may not be as robust in 2009 as it has been in previous years, but it's not as bad as many people think.

Issue Extra: Executive Roundtable—The Future of Pharmaceutical CMC Outsourcing

A Q&A with Pfizer CentreSource, moderated by Jim Miller.
Aug 1, 2009

A Q&A with Pfizer CentreSource, moderated by Jim Miller.

The Future of Pharmaceutical CMC Outsourcing

A roundtable with pharma majors Pfizer and Johnson & Johnson, moderated by Jim Miller.
Aug 1, 2009

A roundtable with pharma majors Pfizer and Johnson & Johnson, moderated by Jim Miller.

Penny-Wise, Pound-Foolish

Pharma companies that sell redundant facilities could endanger their supply chains.
Jul 8, 2009

Pharma companies that sell redundant facilities could endanger their supply chains.

Limits to Growth?

A major CRO ventures further into proprietary drug development.
Jun 8, 2009

A major CRO ventures further into proprietary drug development.

Penny-Wise, Pound-Foolish

Pharma companies that sell redundant facilities could endanger their supply chains.
Jun 2, 2009

Pharma companies that sell redundant facilities could endanger their supply chains.

Contract Organizations are the Sell of the Season

Despite the market downturn, private equity investors are lining up for pharmaceutical services.
May 6, 2009

Despite the market downturn, private equity investors are lining up for pharmaceutical services.

Limits to Growth?

A major CRO ventures further into proprietary drug development.
May 2, 2009

A major CRO ventures further into proprietary drug development.

The New Normal: The Changing Face of Pharma

When the business environment returns to "normal," our industry may appear quite different.
Apr 8, 2009

When the business environment returns to "normal," our industry may appear quite different.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
30%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
FindPharma Custom Search
Click here